Xeris Biopharma Holdings (XERS) Deferred Taxes (2022 - 2024)
Xeris Biopharma Holdings' (XERS) quarterly Deferred Taxes came in at -$3.3 million in Q3 2024, down 592.44% YoY from $675000.0 in Q4 2023, and down 543.79% on a QoQ basis from $749000.0 in Q2 2024.
Xeris Biopharma Holdings (XERS) Deferred Taxes (2022 - 2024) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 3 years of Deferred Taxes data on file, last reported at -$3.3 million in Q3 2024.
- Quarterly Deferred Taxes fell 592.44% year-over-year to -$3.3 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$3.3 million (down 789.63% YoY) and the FY2024 annual result came in at -$2.3 million, down 81.59% from the prior year.
- Deferred Taxes eased to -$3.3 million in Q3 2024, from $749000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $749000.0 in Q2 2024 to a low of -$3.3 million in Q3 2024.
- A 3-year average of -$494100.0 and a median of -$148500.0 in 2022 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes jumped 538.31% — and 2024, when it plunged 592.44%.
- Tracing XERS's Deferred Taxes over 3 years: stood at -$1.2 million in 2022, then retreated by 5.31% to -$1.2 million in 2023, then slumped by 166.13% to -$3.3 million in 2024.
- The last three Deferred Taxes figures came in at -$3.3 million (Q3 2024), $749000.0 (Q2 2024), and $307000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | 749,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | -1.25 Mn |
| Sep 30, 2023 | 675,000.00 |
| Jun 30, 2023 | -675,000.00 |
| Dec 31, 2022 | -1.19 Mn |
| Sep 30, 2022 | -154,000.00 |
| Jun 30, 2022 | -143,000.00 |
| Mar 31, 2022 | 59,000.00 |